Author Correction: Preclinical comparison of prolgolimab, pembrolizumab and nivolumab.
Gordeev A, Vaal A, Puchkova M, Smirnova I, Doronin A, Znobishcheva A, Zhmudanova D, Aleksandrov A, Sukchev M, Imyanitov E, Solovyev V, Iakovlev P.
Gordeev A, et al. Among authors: aleksandrov a.
Sci Rep. 2024 Nov 6;14(1):26915. doi: 10.1038/s41598-024-77480-w.
Sci Rep. 2024.
PMID: 39505987
Free PMC article.
No abstract available.